Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pulmonary Hypertension Institutional Registry (RIHP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by Hospital Italiano de Buenos Aires.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Diego Giunta, Hospital Italiano de Buenos Aires Identifier:
First received: June 16, 2011
Last updated: December 26, 2011
Last verified: December 2011

The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

Resource links provided by NLM:

Further study details as provided by Hospital Italiano de Buenos Aires:

Primary Outcome Measures:
  • Pulmonary hypertension prevalence and incidence [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    The main goal is to describe Pulmonary hypertension prevalence and incidence in our community as well as depict its risk factors, symptoms, prognosis and treatment response.

Secondary Outcome Measures:
  • Mortality rate [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 100000
Study Start Date: December 2010
Detailed Description:

The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension, and excludes type II Pulmonary Hypertension. It also includes prevalent cases from our HMO who had diagnosis prior the beginning of the registry.


Ages Eligible for Study:   17 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adults 17 yo or older, Any type of Pulmonary Hypertension except type II


Inclusion Criteria:

  • More 17
  • Pulmonary Hypertension
  • Systolic Pulmonary Pressure >40 mmhg measured in a doppler echocardiogram,
  • Systolic artery pressure <25 in a pulmonary angiography

Exclusion Criteria:

  • Non accept to participate
  • Pulmonary Hypertension type II (Left cardiac disease)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01501838

Contact: Diego H Giunta, MD 00541149590200 ext 4419
Contact: Cristina M Elizondo, MD 00541149590200 ext 4525

Hospital Italiano de Buenos Aires Recruiting
Buenos Aires, Argentina, 1181
Contact: Diego h Giunta, MD    000541149590200 ext 4419   
Contact: Cristina M Elizondo, MD    00541149590200 ext 4419   
Sub-Investigator: Cristina M Elizondo, MD         
Sub-Investigator: Graciela Svetliza, MD         
Sub-Investigator: Norberto Vulcano, MD         
Sponsors and Collaborators
Hospital Italiano de Buenos Aires
Principal Investigator: Diego H Giunta, MD Hospital Italiano de Buenos Aires
  More Information

No publications provided

Responsible Party: Diego Giunta, Principal Investigator, Hospital Italiano de Buenos Aires Identifier: NCT01501838     History of Changes
Other Study ID Numbers: 1487
Study First Received: June 16, 2011
Last Updated: December 26, 2011
Health Authority: Argentina: Human Research Bioethics Committee

Additional relevant MeSH terms:
Hypertension, Pulmonary
Lung Diseases
Respiratory Tract Diseases processed this record on March 03, 2015